SecBot SecBot

LUNG

Pulmonx Corp
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001127537 Healthcare & Medical Devices
$1.92 +0.09 (+4.92%)
Oct 26 4:00 PM ET · prev $1.83
Market cap
$80.7M
Micro cap
Median target
$3.00
+56% · range $2.50–5.00
Next earnings
Oct 27
in 1 day · EPS est. −$0.26
1 year
+23.1%
from $1.56 · Oct 27
30 days
−2.0%
from $1.96
52-week range
$1.17–2.60
−26% from high · low Mar 27
Avg volume 20D
281.0K
shares / day
Short interest
802.7K
≈1.9% of shares · −5.3%
Days to cover
3.2
at average volume
Insider net
−$435.6K
0 buyers · 4 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·Next Earnings date, Oct 27, 2026
Strongest NEUTRAL Pulmonx Corporation announced it will report its Q3 2026 results on October 27, 2026.
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $435.6K.

  • InstitutionsMIXED

    Q2 2026: 16 added (0 new), 20 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.282 → −$0.256 over 90 days. 4 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −5.3% to 802.7K shares. 3.2 days to cover, ≈1.9% of shares.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYTRIM2,922,921$3.8M
ExodusPoint Capital Management, LPTRIM1,223,555$1.6M
BlackRock, Inc.TRIM882,490$1.1M
JANE STREET GROUP, LLCDOUBLED758,231$985.7K
GEODE CAPITAL MANAGEMENT, LLCTRIM452,684$588.7K
RENAISSANCE TECHNOLOGIES LLCADD425,110$552.6K
DEUTSCHE BANK AG\TRIM402,316$523.0K
Centiva Capital, LPADD200,095$260.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026
12-month targets · 5 analysts

Price is below the lowest target. Median implies +56%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Apr 30, 2026D. Boral Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$435.6K
sold · 4 insiders
DateInsiderTypeValue
Sep 1, 2026
Lehman David Aaron
General Counsel
SELL$8.6K
Sep 1, 2026
Lehman David Aaron
General Counsel
SELL$5.0K
Sep 1, 2026
Lehman David Aaron
General Counsel
SELL$7.9K
Sep 1, 2026
Lehman David Aaron
General Counsel
SELL$10.9K
Sep 1, 2026
Rose Geoffrey Beran
Chief Commercial Officer
SELL$3.9K
Sep 1, 2026
Rose Geoffrey Beran
Chief Commercial Officer
SELL$3.5K
Sep 1, 2026
Rose Geoffrey Beran
Chief Commercial Officer
SELL$5.0K
Sep 1, 2026
Rose Geoffrey Beran
Chief Commercial Officer
SELL$5.4K

Earnings setup

Estimates
Oct 27
reports in 1 day
−$0.26
EPS estimate, this quarter
+9%
estimate change, 90 days
4↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.26-$0.28–-$0.23+10.5%$21.9M
Next Q-$0.22-$0.24–-$0.17+13.5%$25.3M
Current FY-$1.04-$1.09–-$0.97+8.6%$90.5M
Next FY-$0.94-$1.08–-$0.80+9.8%$98.3M

Short side

FINRA· Sep 30, 2026
802,733
shares short
-5.3%
vs prior settlement
3.2
days to cover
≈1.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
Pulmonx Corporation announced it will report its Q3 2026 results on October 27, 2026.
PRESS-RELEASE — Impact 1/10
Oct 13, 2026 Earnings
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
REDWOOD CITY, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx
Sep 1, 2026 Insider
Lehman David Aaron sold 3,807 shares
General Counsel @ $2.26 ($8.6K)
Sep 1, 2026 Insider
Lehman David Aaron sold 2,224 shares
General Counsel @ $2.26 ($5.0K)
Sep 1, 2026 Insider
Lehman David Aaron sold 3,476 shares
General Counsel @ $2.26 ($7.9K)
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
2,922,921 shares ($3.8M)
Jun 30, 2026 Inst.
ExodusPoint Capital Management, LP — TRIM
1,223,555 shares ($1.6M)
Jun 3, 2026 SEC
Four Pulmonx insiders, including the CEO and General Counsel, sold a total of $34K in shares over a three-day window…
CLUSTER — Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 27, 2026
Earnings date
LUNG Q3 2026 Earnings After Market Close — 2026-10-27
Recent
Oct 13, 2026
Earnings
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
REDWOOD CITY, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive…
Sep 1, 2026
Press release
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in…
Jul 29, 2026
Earnings date
LUNG Q2 2026 Earnings After Market Close — 2026-07-29
Jun 30, 2026
Short interest
Short Interest: LUNG down 49% to 1.1M shares
Settlement 2026-06-30 | Days to cover: 1.33 | ≈2.72% of shares outstanding (est.)
Jun 1, 2026
Activist
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in…

SecBot reports

8 filings · 1 press release · 0 bullish · 1 bearish · 1 mixed · 6 neutral
All LUNG filing & press-release reports (9)